Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): William Herrington Added: 1 year ago
Long-term cardio-renal outcomes investigating empagliflozin (Boehringer Ingelheim) on kidney disease progression (KDP) or cardiovascular death in patients with pre-existing chronic kidney disease.In this short interview, Prof William Herrington (Nuffield Department of Population Health, University of Oxford, Oxford, UK) discusses the findings from EMPA-KIDNEY (NCT03594110).EMPA-KIDNEY is an… View more
Job title: Interventional Cardiologist
DrGasparini is an Interventional Cardiologist atHumanitas Research Hospital, Italy. He is specialized in treatment of complex coronary artery disease, such as chronic total occlusions, saphenous vein grafts, bifurcations, left main disease and in management of complications.He is CTO operator, proctor and educator. He is the Founder and Course Director of the CTO Live Aid event. Dr… View more
Research Area(s) / Expertise:
Dr Ali is a board-certified cardiologist specialising in interventional and structural cardiology atSt Francis Hospital and Heart Centerin Roslyn, New York. Ziad is an internationally renowned expert in complex high-risk indicated percutaneous coronary interventions (CHIP) including the treatment of chronic total occlusions (CTO) where the arteries in the heart become completely blocked. … View more
Research Area(s) / Expertise: Job title: Interventional Cardiologist
Interventional Cardiologist, Instituto Cardiovascular de Buenos Aires (ICBA) His areas of interest have centered around Coronary, complex angioplasty, chronic total occlusion angioplasty and structural heart disease interventions. View more
Job title: Interventional Cardiologist
Dr Sanjog Kalra is an Interventional Cardiologist at University of Toronto, Toronto, CA. He specialises in complex, high risk coronary revascularisation, chronic total occlusion and mechanical circulatory support. View more
Author(s): Purvi Parwani Added: 1 month ago
Dr Purvi Parwani (Loma Linda University Health, US) recaps the standout science from Day 2 of ACC 2026, a day defined by a central theme: challenging long-held assumptions in cardiology. Her summary focuses on what these updates mean for day-to-day clinical practice, from prevention strategies to interventional decision-making.Prevention and Risk ReductionVESALIUS-CV: Showed a 25% reduction in… View more